Utama › Kanser Paru-paru Bukan Sel Kecil › Illinois › Waukegan
Kajian klinikal Kanser Paru-paru Bukan Sel Kecil di Waukegan, IL
16 kajian untuk Kanser Paru-paru Bukan Sel Kecil sedang mencari peserta di lokasi dalam dan sekitar Waukegan (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Mengambil pesertaFasa 3
- AMG Libertyville - Oncology, Libertyville · 8 mi jauh
- Condell Memorial Hospital, Libertyville · 8 mi jauh
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
Mengambil pesertaFasa 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauh
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Mengambil pesertaFasa 2
- City of Hope Chicago, Zion · 6 mi jauh
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Mengambil pesertaFasa 3
- Advocate Medical Group - Libertyville Oncology, Libertyville · 8 mi jauh
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- Captain James A. Lovell Federal Health Care Center, North Chicago · 3 mi jauh
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
Mengambil pesertaFasa 3
- City of Hope® Cancer Center Chicago, Zion · 6 mi jauh
Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic Alterations
Mengambil pesertaFasa 3
- Research Site, Zion · 6 mi jauh
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
Mengambil pesertaFasa 3
- Research Site, North Chicago · 3 mi jauh
Radiotherapy to Block Oligoprogression In Metastatic Non-Small-Cell Lung Cancer
Mengambil pesertaFasa 3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauh
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
Mengambil pesertaFasa 3
- Cancer Treatment Centers of America (CTCA), Zion · 6 mi jauh
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- AMG Libertyville - Oncology, Libertyville · 8 mi jauh
- Condell Memorial Hospital, Libertyville · 8 mi jauh
- dan 1 lagi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- AMG Libertyville - Oncology, Libertyville · 8 mi jauh
- Condell Memorial Hospital, Libertyville · 8 mi jauh
- dan 1 lagi
Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2/3
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- AMG Libertyville - Oncology, Libertyville · 8 mi jauh
- Condell Memorial Hospital, Libertyville · 8 mi jauh
- dan 1 lagi
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Mengambil pesertaFasa 2
- Northwestern Medicine Lake Forest Hospital, Lake Forest · 7 mi jauh
- Northwestern Medicine Grayslake Outpatient Center, Grayslake · 10 mi jauh
Immunotherapy Biomarkers to Predict First-line PD(L)1-based Immunotherapy Response and Selection of Second-line Treatment in Stage IIIB-IV Non-small Cell Lung Cancer, IMMUNO-BIOMAP Trial
Mengambil pesertaFasa 2
- City of Hope at Chicago, Zion · 6 mi jauh
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Mengambil pesertaKajian pemerhatian
- AMG Libertyville - Oncology, Libertyville · 8 mi jauh
- Condell Memorial Hospital, Libertyville · 8 mi jauh
Kajian Kanser Paru-paru Bukan Sel Kecil di bandar lain
- Houston, TX145 kajian
- New York City, NY121 kajian
- Arlington, VA104 kajian
- Nashville, TN97 kajian
- Boston, MA90 kajian
- Los Angeles, CA87 kajian
- St. Louis, MO73 kajian
- Chicago, IL61 kajian
- Baltimore, MD60 kajian
- San Antonio, TX59 kajian
- Columbus, OH57 kajian
- Washington, DC55 kajian
Kajian lain di Waukegan
- Kanser Paru-paru16 kajian
- Kanser Payudara12 kajian
- Kolitis Ulseratif7 kajian
- Kanser Ginjal (Karsinoma Sel Renal)7 kajian
- Kanser Ovari6 kajian
- Kanser Metastatik6 kajian
- Karsinoma Sel Skuamosa Kepala dan Leher6 kajian
- Kanser Kolorektal6 kajian
- Kanser Prostat6 kajian
- Melanoma5 kajian
- Leukemia Mieloid Akut5 kajian
- Penyakit Crohn5 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 6 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.